Skip to content

Preliminary study on the efficacy and mechanism of Wuqinxi in managing cancer-related fatigue in patients with stage III–IV lung cancer

Preliminary study on the efficacy and mechanism of Wuqinxi in managing cancer-related fatigue in patients with stage III–IV lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002159
Enrollment
Unknown
Registered
2025-11-08
Start date
2023-04-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer related fatigue in lung cancer patients

Interventions

experimental group:On the basis of conventional care, combined with the bear-bird routines of Wuqinxi training
control group:Routine nursing combined with walking

Sponsors

The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with lung cancer confirmed by biopsy or pathology and receiving palliative care; (2) TNM (tumor-node-metastasis) stage III-IV disease; (3) Aged 18-75 years; (4) Meeting diagnostic criteria for cancer-related fatigue (CRF) per ICD-10 Revision Conference: Fatigue symptoms persisting =2 weeks with =5 of the following: 1)Generalized weakness or heavy limbs 2) Impaired concentration 3) Diminished motivation depressed mood or reduced energy 4) Insomnia or hypersomnia 5) Non-restorative sleep 6) Perceived exertion during routine activities 7) Emotional lability (sadness frustration irritability) 8) Impaired activities of daily living 9) Short-term memory deficits 10) Post-exertional malaise lasting >4 hours (5) Cognitively intact with questionnaire completion ability and CRF scale compliance; (6) Karnofsky Performance Status (KPS) =50 and life expectancy >6 months.

Exclusion criteria

Exclusion criteria: (1) patients with non-cancer-related fatigue; (2) patients with severe liver and kidney damage or cardiovascular disease; (3) mental abnormality, can not cooperate with treatment.

Design outcomes

Primary

MeasureTime frame
cancer related fatigue;pittsburgh sleep quality index;functional assessment of cancer therapy;

Secondary

MeasureTime frame
Blood test;

Countries

China

Contacts

Public ContactZhao Yuling

Nursing Department of the First Affiliated Hospital of Guangxi University of Chinese Medicine

27300905@qq.com18260850964

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026